SCHEMBL6162446

SCHEMBL6162446

COc1ccc(CNC(=O)c2c[nH]c3c(c2=O)CCC3)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CHRM4 P08173 2/20 0.42
KCNK3 O14649 1/20 0.41
KCNK5 O95279 1/20 0.41
KCNA5 P22460 1/20 0.41
KCNK17 Q96T54 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
PDE7B Q9NP56 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162568 0.98 LMNA (0.43) KDM4ELMNAHSD17B10CHRM4KCNK3
SCHEMBL6161505 0.90 POLB (0.47) KDM4ELMNAHSD17B10MEN1NPC1
SCHEMBL6162486 0.90 PDE4A (0.39) KDM4ELMNAHSD17B10CHRM4KCNK3
SCHEMBL6161355 0.89 HTT (0.40) KDM4ELMNAHSD17B10MEN1KMT2A
SCHEMBL6164858 0.89 PDE4A (0.39) KCNK3KCNK5KCNA5KCNK17KCNK9
SCHEMBL6163159 0.89 POLB (0.47) KDM4ELMNAHSD17B10KCNK3KCNK5
SCHEMBL6162143 0.83 ADORA2A (0.57) ADORA2AADORA1MEN1RAB9AKMT2A
SCHEMBL6164599 0.82 ADORA2A (0.58) ADORA2AADORA1MEN1RAB9AKMT2A
SCHEMBL6160973 0.82 GABRP (0.46) LMNAMEN1NPC1RAB9AKMT2A
SCHEMBL6163180 0.82 NPC1 (0.58) KDM4ENPC1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP claimed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP disclosed